{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:12:31Z","timestamp":1785255151385,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,30]]},"DOI":"10.7759\/cureus.26463","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T17:51:08Z","timestamp":1656611468000},"source":"Crossref","is-referenced-by-count":23,"title":["Role of Probiotics in the Management of Helicobacter pylori"],"prefix":"10.7759","author":[{"given":"Andrea","family":"Mestre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajalakshmi","family":"Sathiya Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deliana","family":"Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jobby","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Ali","family":"Abdulqader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja Chandra","family":"Chakinala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i37.5578","article-title":"Pathogenesis and clinical management of Helicobacter pylori gastric infection","volume":"25","author":"de Brito BB","year":"2019","unstructured":"de Brito BB, da Silva FA, Soares AS, et al.. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019, 25:5578-89. 10.3748\/wjg.v25.i37.5578","journal-title":"World J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-017-8535-7","article-title":"Helicobacter pylori treatment: antibiotics or probiotics","volume":"102","author":"Goderska K","year":"2018","unstructured":"Goderska K, Agudo Pena S, Alarcon T. Helicobacter pylori treatment: antibiotics or probiotics. Appl Microbiol Biotechnol. 2018, 102:1-7. 10.1007\/s00253-017-8535-7","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2018.08.028","article-title":"The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, randomized clinical trial","volume":"35","author":"Chen L","year":"2018","unstructured":"Chen L, Xu W, Lee A, et al.. The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: an open-label, randomized clinical trial. EBioMedicine. 2018, 35:87-96. 10.1016\/j.ebiom.2018.08.028","journal-title":"EBioMedicine"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-37-2-123","article-title":"Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori","volume":"37","author":"Eaton KA","year":"1992","unstructured":"Eaton KA, Morgan DR, Krakowka S. Motility as a factor in the colonisation of gnotobiotic piglets by Helicobacter pylori. J Med Microbiol. 1992, 37:123-7. 10.1099\/00222615-37-2-123","journal-title":"J Med Microbiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.7.4335-4339.2000","article-title":"Adherence of isogenic flagellum-negative mutants of Helicobacter pylori and Helicobacter mustelae to human and ferret gastric epithelial cells","volume":"68","author":"Clyne M","year":"2000","unstructured":"Clyne M, Ocroinin T, Suerbaum S, Josenhans C, Drumm B. Adherence of isogenic flagellum-negative mutants of Helicobacter pylori and Helicobacter mustelae to human and ferret gastric epithelial cells. Infect Immun. 2000, 68:4335-9. 10.1128\/IAI.68.7.4335-4339.2000","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1128\/JB.182.6.1459-1471.2000","article-title":"Signaling components in bacterial locomotion and sensory reception","volume":"182","author":"Aizawa SI","year":"2000","unstructured":"Aizawa SI, Harwood CS, Kadner RJ. Signaling components in bacterial locomotion and sensory reception. J Bacteriol. 2000, 182:1459-71. 10.1128\/JB.182.6.1459-1471.2000","journal-title":"J Bacteriol"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Food and Agriculture Organization of the United Nations (FAO). In. Encyclopedia of Global Health. (2008). Accessed: June 1, 2022: http:\/\/dx.doi.org\/10.4135\/9781412963855.n464.","DOI":"10.4135\/9781412963855.n464"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2009.00743.x","article-title":"Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature","volume":"15","author":"Lionetti E","year":"2010","unstructured":"Lionetti E, Indrio F, Pavone L, Borrelli G, Cavallo L, Francavilla R. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter. 2010, 15:79-87. 10.1111\/j.1523-5378.2009.00743.x","journal-title":"Helicobacter"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/137.3.812S","article-title":"Helicobacter pylori and probiotics","volume":"137","author":"Lesbros-Pantoflickova D","year":"2007","unstructured":"Lesbros-Pantoflickova D, Corth\u00e9sy-Theulaz I, Blum AL. Helicobacter pylori and probiotics. J Nutr. 2007, 137:812S-8S. 10.1093\/jn\/137.3.812S","journal-title":"J Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2007.03279.x","article-title":"Isolation, taxonomic identification and hydrogen peroxide production by Lactobacillus delbrueckii subsp. lactis T31, isolated from Mongolian yoghurt: inhibitory activity on food-borne pathogens","volume":"103","author":"Batdorj B","year":"2007","unstructured":"Batdorj B, Trinetta V, Dalgalarrondo M, et al.. Isolation, taxonomic identification and hydrogen peroxide production by Lactobacillus delbrueckii subsp. lactis T31, isolated from Mongolian yoghurt: inhibitory activity on food-borne pathogens. J Appl Microbiol. 2007, 103:584-93. 10.1111\/j.1365-2672.2007.03279.x","journal-title":"J Appl Microbiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6918(03)00070-2","article-title":"Probiotics and Helicobacter pylori.","volume":"17","author":"Felley C","year":"2003","unstructured":"Felley C, Michetti P. Probiotics and Helicobacter pylori. . Best Practice Res Clin Gastroenterol. 2003, 17:785-91. 10.1016\/s1521-6918(03)00070-2","journal-title":"Best Practice Res Clin Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.7.3925","article-title":"Epithelial attachment alters the outcome of Helicobacter pylori infection","volume":"95","author":"Guruge JL","year":"1998","unstructured":"Guruge JL, Falk PG, Lorenz RG, et al.. Epithelial attachment alters the outcome of Helicobacter pylori infection. Proc Natl Acad Sci U S A. 1998, 95:3925-30. 10.1073\/pnas.95.7.3925","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2016.0278","article-title":"Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance","volume":"28","author":"\u00c7ekin AH","year":"2017","unstructured":"\u00c7ekin AH, \u015eahint\u00fcrk Y, Akbay Harmandar F, Uyar S, Yolcular BO, \u00c7ekin Y. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance. Turk J Gastroenterol. 2017, 28:3-11. 10.5152\/tjg.2016.0278","journal-title":"Turk J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12270","article-title":"The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial","volume":"21","author":"Oh B","year":"2016","unstructured":"Oh B, Kim BS, Kim JW, et al.. The effect of probiotics on gut microbiota during the Helicobacter pylori eradication: randomized controlled trial. Helicobacter. 2016, 21:165-74. 10.1111\/hel.12270","journal-title":"Helicobacter"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i1.139","article-title":"Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis","volume":"24","author":"Losurdo G","year":"2018","unstructured":"Losurdo G, Cubisino R, Barone M, Principi M, Leandro G, Ierardi E, Di Leo A. Probiotic monotherapy and Helicobacter pylori eradication: a systematic review with pooled-data analysis. World J Gastroenterol. 2018, 24:139-49. 10.3748\/wjg.v24.i1.139","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-013-1013-z","article-title":"Lactobacillus reuteri in the treatment of Helicobacter pylori infection","volume":"9","author":"Dore MP","year":"2014","unstructured":"Dore MP, Cuccu M, Pes GM, Manca A, Graham DY. Lactobacillus reuteri in the treatment of Helicobacter pylori infection. Intern Emerg Med. 2014, 9:649-54. 10.1007\/s11739-013-1013-z","journal-title":"Intern Emerg Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12848","article-title":"The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults","volume":"26","author":"Yuan Z","year":"2021","unstructured":"Yuan Z, Xiao S, Li S, et al.. The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults. Helicobacter. 2021, 26:e12848. 10.1111\/hel.12848","journal-title":"Helicobacter"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030632","article-title":"A four-probiotics regimen combined with a standard Helicobacter pylori-eradication treatment reduces side effects and increases eradication rates","volume":"14","author":"Viazis N","year":"2022","unstructured":"Viazis N, Argyriou K, Kotzampassi K, et al.. A four-probiotics regimen combined with a standard Helicobacter pylori-eradication treatment reduces side effects and increases eradication rates. Nutrients. 2022, 14:632. 10.3390\/nu14030632","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015180","article-title":"Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis","volume":"98","author":"Shi X","year":"2019","unstructured":"Shi X, Zhang J, Mo L, Shi J, Qin M, Huang X. Efficacy and safety of probiotics in eradicating Helicobacter pylori: a network meta-analysis. Medicine (Baltimore). 2019, 98:e15180. 10.1097\/MD.0000000000015180","journal-title":"Medicine (Baltimore)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.17235\/reed.2021.7931\/2021","article-title":"Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori","volume":"114","author":"M\u00e1rquez CM","year":"2022","unstructured":"M\u00e1rquez CM, \u00c1lvarez PF, Delgado TV, Laria LC, Arias FA, \u00c1lvarez \u00c1C, Rodr\u00edguez BJG. Randomized, double-blind, placebo-controlled clinical trial on the usefulness of probiotic Lactobacillus reuteri in bismuth-containing quadruple eradication therapy for infection with Helicobacter pylori. Rev Esp Enferm Dig. 2022, 114:89-95. 10.17235\/reed.2021.7931\/2021","journal-title":"Rev Esp Enferm Dig"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209205","article-title":"Choosing an appropriate probiotic product for your patient: an evidence-based practical guide","volume":"13","author":"Sniffen JC","year":"2018","unstructured":"Sniffen JC, McFarland LV, Evans CT, Goldstein EJ. Choosing an appropriate probiotic product for your patient: an evidence-based practical guide. PLoS One. 2018, 13:e0209205. 10.1371\/journal.pone.0209205","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.3507","article-title":"Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"307","author":"Hempel S","year":"2012","unstructured":"Hempel S, Newberry SJ, Maher AR, et al.. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 2012, 307:1959-69. 10.1001\/jama.2012.3507","journal-title":"JAMA"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100752-role-of-probiotics-in-the-management-of-helicobacter-pylori","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:15Z","timestamp":1707507855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100752-role-of-probiotics-in-the-management-of-helicobacter-pylori"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,30]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.26463","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,30]]}}}